Molecular markers for diagnosis and prognosis in cervical neoplasia
PhD ceremony: Mr. J.J.H. Eijsink, 14.45 uur, Academiegebouw, Broerstraat 5, Groningen
Title: Molecular markers for diagnosis and prognosis in cervical neoplasia
Promotor(s): prof. A.G.J. van der Zee, prof. H. Hollema, prof. G.H. de Bock
Faculty: Medical Sciences
Population-based screening has reduced the incidence of cervical cancer significantly in Western countries, but there is still room for improvement. A test based on detection of DNA methylation appears to be an attractive tool for cervical neoplasia screening because gene promoter methylation marks an early event in cervical carcinogenesis. In this thesis a methylation test for cervical cancer using four methylation markers was developed and evaluated. The test has the potential to detect 95% of cervical cancers and 65% of high-grade premalignant lesions. It was also shown that the methylation test is feasible on cervico-vaginal lavages obtained by a self-sampling device. A self-sampling approach may be a useful alternative screening strategy because 30% of the Dutch women do not attend the screening programme, and almost half of the cervical cancer patients are diagnosed in this population.
Last modified: | 13 March 2020 01.10 a.m. |
More news
-
27 August 2024
UMCG gaat onderzoeksfaciliteiten beschikbaar stellen voor geneesmiddelenontwikkeling
Om de beschikbaarheid en effectiviteit van geneesmiddelen in Nederland te verbeteren gaat het UMCG het bedrijf G² Solutions opzetten. Dit bedrijf moet ervoor gaan zorgen dat belangrijke technologische ontwikkelingen op het gebied van DNA sequencing...
-
17 July 2024
Veni-grants for ten researchers
The Dutch Research Council (NWO) has awarded a Veni grant of up to €320,000 each to ten researchers of the University of Groningen and the UMCG. The Veni grants are designed for outstanding researchers who have recently gained a PhD.
-
16 July 2024
Medicine still subjects to male bias
Aranka Ballering studied the course of illness in people with common symptoms. One of the most striking findings to emerge from her research was that on average, women have a different – and less extensive – course of illness than men.